172 related articles for article (PubMed ID: 22205645)
1. Domain III regulates N-type (CaV2.2) calcium channel closing kinetics.
Yarotskyy V; Gao G; Peterson BZ; Elmslie KS
J Neurophysiol; 2012 Apr; 107(7):1942-51. PubMed ID: 22205645
[TBL] [Abstract][Full Text] [Related]
2. Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine.
Buraei Z; Anghelescu M; Elmslie KS
Biophys J; 2005 Sep; 89(3):1681-91. PubMed ID: 15951378
[TBL] [Abstract][Full Text] [Related]
3. Roscovitine differentially affects CaV2 and Kv channels by binding to the open state.
Buraei Z; Schofield G; Elmslie KS
Neuropharmacology; 2007 Mar; 52(3):883-94. PubMed ID: 17125805
[TBL] [Abstract][Full Text] [Related]
4. Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed-state inactivation.
Yarotskyy V; Elmslie KS
J Pharmacol Exp Ther; 2012 Feb; 340(2):463-72. PubMed ID: 22088954
[TBL] [Abstract][Full Text] [Related]
5. Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation.
Yarotskyy V; Gao G; Du L; Ganapathi SB; Peterson BZ; Elmslie KS
J Biol Chem; 2010 Jan; 285(1):43-53. PubMed ID: 19887376
[TBL] [Abstract][Full Text] [Related]
6. Open-state occupancy prevents gating charge relaxation of N-type (CaV2.2) calcium channels.
Yarotskyy V; Elmslie KS
Biophys J; 2009 Nov; 97(9):2446-55. PubMed ID: 19883587
[TBL] [Abstract][Full Text] [Related]
7. (R)-roscovitine prolongs the mean open time of unitary N-type calcium channel currents.
DeStefino NR; Pilato AA; Dittrich M; Cherry SV; Cho S; Stiles JR; Meriney SD
Neuroscience; 2010 May; 167(3):838-49. PubMed ID: 20188151
[TBL] [Abstract][Full Text] [Related]
8. Origin of the voltage dependence of G-protein regulation of P/Q-type Ca2+ channels.
Zhang Y; Chen YH; Bangaru SD; He L; Abele K; Tanabe S; Kozasa T; Yang J
J Neurosci; 2008 Dec; 28(52):14176-88. PubMed ID: 19109500
[TBL] [Abstract][Full Text] [Related]
9. Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca(V)1.2) calcium channels.
Yarotskyy V; Elmslie KS
Br J Pharmacol; 2007 Oct; 152(3):386-95. PubMed ID: 17700718
[TBL] [Abstract][Full Text] [Related]
10. New Cav2 calcium channel gating modifiers with agonist activity and therapeutic potential to treat neuromuscular disease.
Wu M; White HV; Boehm BA; Meriney CJ; Kerrigan K; Frasso M; Liang M; Gotway EM; Wilcox MR; Johnson JW; Wipf P; Meriney SD
Neuropharmacology; 2018 Mar; 131():176-189. PubMed ID: 29246857
[TBL] [Abstract][Full Text] [Related]
11. The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation.
Yarotskyy V; Gao G; Peterson BZ; Elmslie KS
J Physiol; 2009 Feb; 587(3):551-65. PubMed ID: 19074970
[TBL] [Abstract][Full Text] [Related]
12. Interaction via a key tryptophan in the I-II linker of N-type calcium channels is required for beta1 but not for palmitoylated beta2, implicating an additional binding site in the regulation of channel voltage-dependent properties.
Leroy J; Richards MW; Butcher AJ; Nieto-Rostro M; Pratt WS; Davies A; Dolphin AC
J Neurosci; 2005 Jul; 25(30):6984-96. PubMed ID: 16049174
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological correction of gating defects in the voltage-gated Ca(v)2.1 Ca²⁺ channel due to a familial hemiplegic migraine mutation.
Inagaki A; Frank CA; Usachev YM; Benveniste M; Lee A
Neuron; 2014 Jan; 81(1):91-102. PubMed ID: 24411734
[TBL] [Abstract][Full Text] [Related]
14. The glutamic acid-rich protein is a gating inhibitor of cyclic nucleotide-gated channels.
Michalakis S; Zong X; Becirovic E; Hammelmann V; Wein T; Wanner KT; Biel M
J Neurosci; 2011 Jan; 31(1):133-41. PubMed ID: 21209198
[TBL] [Abstract][Full Text] [Related]
15. Modal gating of human CaV2.1 (P/Q-type) calcium channels: I. The slow and the fast gating modes and their modulation by beta subunits.
Luvisetto S; Fellin T; Spagnolo M; Hivert B; Brust PF; Harpold MM; Stauderman KA; Williams ME; Pietrobon D
J Gen Physiol; 2004 Nov; 124(5):445-61. PubMed ID: 15504896
[TBL] [Abstract][Full Text] [Related]
16. The N terminus of a schistosome beta subunit regulates inactivation and current density of a Cav2 channel.
Salvador-Recatalà V; Greenberg RM
J Biol Chem; 2010 Nov; 285(46):35878-88. PubMed ID: 20826800
[TBL] [Abstract][Full Text] [Related]
17. CaV2.2 and CaV2.3 (N- and R-type) Ca2+ channels in depolarization-evoked entry of Ca2+ into mouse sperm.
Wennemuth G; Westenbroek RE; Xu T; Hille B; Babcock DF
J Biol Chem; 2000 Jul; 275(28):21210-7. PubMed ID: 10791962
[TBL] [Abstract][Full Text] [Related]
18. G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels.
Agler HL; Evans J; Tay LH; Anderson MJ; Colecraft HM; Yue DT
Neuron; 2005 Jun; 46(6):891-904. PubMed ID: 15953418
[TBL] [Abstract][Full Text] [Related]
19. The separation of antagonist from agonist effects of trisubstituted purines on CaV2.2 (N-type) channels.
Buraei Z; Elmslie KS
J Neurochem; 2008 May; 105(4):1450-61. PubMed ID: 18221369
[TBL] [Abstract][Full Text] [Related]
20. Orientation of the calcium channel beta relative to the alpha(1)2.2 subunit is critical for its regulation of channel activity.
Vitko I; Shcheglovitov A; Baumgart JP; Arias-Olguín II; Murbartián J; Arias JM; Perez-Reyes E
PLoS One; 2008; 3(10):e3560. PubMed ID: 18958281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
